SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IPCA Laboratories halts operations at formulations manufacturing unit in MP

08 Nov 2012 Evaluate

IPCA Laboratories has decided that it will not manufacture any dosage formulations at its oral solid dosage formulations manufacturing facility situated at Pharmazone, SEZ Indore, Pithampur in Madhya Pradesh and the dosage will not be commercialized for the US market. The company had received the USFDA approval in July this year for the above manufacturing unit.

The company has taken this step as during the course of the internal quality assurance review it had noticed a few non-conformances at the said manufacturing unit. The company has voluntarily referred these to the US Food and Drug Administration (USFDA) and the same is under discussion with them for an appropriate resolution. So till the time issue is resolved to the satisfaction of the USFDA the company will not commence operations.

IPCA Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Ipca Laboratories Share Price

1565.55 21.60 (1.40%)
06-May-2026 14:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.10
Dr. Reddys Lab 1321.00
Cipla 1367.20
Zydus Lifesciences 943.25
Lupin 2448.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×